基于患者报告结局的症状监测在前列腺癌术后应用的有效性:多中心随机对照试验方案
这项多中心随机对照试验将在三家医院入组144例前列腺癌手术患者,按1:1随机分为干预组和对照组。干预组接受基于患者报告结局的症状监测,当目标症状(疼痛、疲乏、睡眠紊乱、嗜睡、口干)评分≥4分时由专科临床医生进行干预;对照组接受标准术后护理。主要结局为症状阈值事件数,使用t检验进行组间比较。
要点
- 干预组在目标症状评分≥4分时触发临床医生响应,对照组接受标准术后护理。
- 使用M.D.安德森症状评估量表在基线及术后第1、2、3、5、7、14、28、42、90天采集症状数据。
- 主要结局为症状阈值事件数,采用t检验比较两组差异。
核心结论
- 该试验旨在评估基于微信的症状管理系统在前列腺癌术后早期症状管理中的有效性和安全性。
研究设计与样本
- 多中心随机对照试验,计划在三家医院入组144例前列腺癌手术患者,按1:1比例随机分配至干预组或对照组。
主要发现
- 干预组接受基于患者报告结局的症状监测,当疼痛、疲乏、睡眠紊乱、嗜睡、口干的目标症状评分≥4分时由专科临床医生进行干预。
- 对照组接受标准术后护理,不设患者报告结局触发的警报。
- 症状数据使用M.D.安德森症状评估量表在基线(术前3天)及术后第1、2、3、5、7、14、28、42、90天采集。
- 主要结局为症状阈值事件数,采用t检验进行组间比较。
关键数值与推荐
- 目标症状评分≥4分作为触发临床医生干预的预设阈值。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Surgery remains a primary treatment modality for prostate cancer. However, patients often experience a substantial burden of postoperative symptoms, which can significantly delay recovery and negatively impact quality of life. Patient-reported outcome (PRO)-based symptom management has emerged as a promising approach to support patient-centered care. Despite its growing importance, there is a lack of clinical trial evidence evaluating early postoperative symptom management in prostate cancer patients. We propose a multicenter randomized controlled trial to assess the effectiveness of a PRO-based symptom monitoring program with threshold-triggered alerts and clinician responses in promoting postoperative recovery in this population. METHODS: This study will enroll 144 patients with prostate cancer across three hospitals. Participants will be randomly assigned in a 1:1 ratio to either the intervention or control group. The intervention group will receive PRO-based symptom monitoring, whereby specialist clinicians will intervene when scores for target symptoms-pain, fatigue, disturbed sleep, drowsiness, and dry mouth-reach a predefined threshold (score ≥ 4). The control group will receive standard postoperative care without PRO-triggered alerts. Symptom data will be collected using the M.D. Anderson Symptom Inventory at baseline (3 days before surgery) and on postoperative days 1, 2, 3, 5, 7, 14, 28, 42, and 90. The primary outcome-the number of symptom threshold events-will be compared between groups using a t-test. DISCUSSION: This trial aims to investigate early-phase postoperative symptom management in patients undergoing prostate cancer surgery. Specifically, it will evaluate the efficacy and safety of a WeChat-based symptom management system in postoperative care. TRIALS REGISTRATION: This trial was registered in the Chinese Clinical Trial Registry (ChiCTR2400082090) on 20 March 2024, and the registration details are available at https://www.chictr.org.cn/showproj.html?proj=214038.
引用
- Hu S, Wang C, Gu T, et al. Effectiveness of patient-reported outcome-based symptom monitoring after prostate cancer surgery: protocol for a multicenter, randomized controlled trial. Trials. 2026. PMID: 41723520. doi:10.1186/s13063-026-09569-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。